Molecular basis of Siglec-10 ligand recognition and antibody blockade
Authors:
- Klaudia SobczakKSKlaudia Sobczak
- Asier Antoñana-VildosolaAAAsier Antoñana-Vildosola
- Pablo ValverdePVPablo Valverde
- Eunate Valdaliso-DíezEVEunate Valdaliso-Díez
- Amaia MentxakaAMAmaia Mentxaka
- Maria Alejandra TravecedoMTMaria Alejandra Travecedo
- Edward N. SchmidtESEdward N. Schmidt
- Larissa HeinzeLHLarissa Heinze
- Iker OyenarteIOIker Oyenarte
- Maria Elena LaugieriMLMaria Elena Laugieri
Preprint
Abstract
Siglec-10 is a sialic acid-binding immunoglobulin-like lectin implicated in immune regulation, yet the molecular basis for ligand recognition and how this is functionally linked to immune modulation remains poorly defined. Herein, we present a multidisciplinary study encompassing structural, biochemical, and cellular approaches to elucidate Siglec-10-carbohydrate interactions and their functional consequences. The crystal structure of the extracellular domain of Siglec-10 in complex with α2-6 sialyllactose revealed the presence of two key arginine residues within the Siglec-10 binding site that interact with the carboxyl group of sialic acid, the canonical R119 and R127, suggesting potential dual contributions to ligand engagement. Saturation Transfer Difference (STD)-Nuclear Magnetic Resonance (NMR) confirmed that R119 is essential for sialoglycan binding in solution, whereas R127 appears dispensable for interactions with glycans under these conditions. In contrast, cell-based binding assays using primary human T cells and engineered monocytic lines demonstrated that both arginine residues (R119 and R127) are critical for cellular recognition, revealing a context-dependent interaction. By obtaining direct images at a molecular resolution of 6-7 nm, super-resolution microscopy further revealed glycan-independent dimerization of the Siglec-10 receptor on the surface of human monocytes. Ligand blockade mediated by anti-Siglec-10 mAb (clone S10A) restores CAR-T cell cytotoxicity in vitro , supporting its role as an immune checkpoint receptor. Finally, although CD24 was not identified as a Siglec-10 ligand on T cells, proximity labeling and mass spectrometry uncovered other sialylated glycoproteins that may mediate this interaction. Together, these results identify Siglec-10 as a modulatory receptor with structural and functional features distinct from other Siglec family members and highlight its potential for therapeutic targeting in cancer immunotherapy.Keywords
This publication has 70 references indexed in Scilit:
- Carbohydrate sulfation as a critical modulator of siglec-sialoglycan interactionsCarbohydrate Research, 2025
- The molecular basis of immunosuppression by soluble CD52 is defined by interactions of N-linked and O-linked glycans with HMGB1 box BJournal of Biological Chemistry, 2025
- Flow Cytometry-Based Detection of Siglec Ligands2023
- Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding FragmentsJournal of Molecular Biology, 2018
- CHARMM‐GUI: A web‐based graphical user interface for CHARMMJournal of Computational Chemistry, 2008
- GLYCAM06: A generalizable biomolecular force field. CarbohydratesJournal of Computational Chemistry, 2007
- Inference of Macromolecular Assemblies from Crystalline StateJournal of Molecular Biology, 2007
- Comparison of multiple Amber force fields and development of improved protein backbone parametersProteins: Structure, Function, and Bioinformatics, 2006
- Ganglioside binding pattern of CD33-related siglecsBioorganic & Medicinal Chemistry Letters, 2003
- Molecular Dynamics in Systems with Multiple Time Scales: Reference System Propagator Algorithms1999